Refine your search
Availability
-
Authors
-
Topics
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors
- Antineoplastic Agents, Immunological
- Brain
- ErbB Receptors
- Fatal Outcome
- Female
- Humans
- Immune Checkpoint Inhibitors
- Immunologic Factors
- Immunotherapy
- Leukoencephalopathy, Progressive Multifocal
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Molecular Targeted Therapy
- Multiple Sclerosis, Relapsing-Remitting
- Natalizumab
- Neoplasms
- Show more
- Show less
-
Languages